CEVIMELINE N-OXIDE

C[C@H]1O[C@]2(CS1)C[N+]3([O-])CCC2CC3

InChIKey=DWWHPWWQQISZCA-XEAZBWPWSA-N

InChI=1S/C10H17NO2S/c1-8-13-10(7-14-8)6-11(12)4-2-9(10)3-5-11/h8-9H,2-7H2,1H3/t8-,9?,10-,11?/m0/s1

Stereochemistry	EPIMERIC
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Substance Class	Chemical Created by `admin` on `Sat Dec 16 09:40:01 UTC 2023` Edited by `admin` on `Sat Dec 16 09:40:01 UTC 2023`
Record UNII	SFN0QB7EYE
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

CEVIMELINE N-OXIDE

Common Name

English

SPIRO(1-AZABICYCLO(2.2.2)OCTANE-3,5'-(1,3)OXATHIOLANE), 2'-METHYL-, 1-OXIDE, (2'R,3R)-REL-

Systematic Name

English

Code System Code Type Description

EPA CompTox

DTXSID40747306

Created by admin on Sat Dec 16 09:40:01 UTC 2023 , Edited by admin on Sat Dec 16 09:40:01 UTC 2023

PRIMARY

PUBCHEM

91810650

Created by admin on Sat Dec 16 09:40:01 UTC 2023 , Edited by admin on Sat Dec 16 09:40:01 UTC 2023

PRIMARY

CAS

469890-14-0

Created by admin on Sat Dec 16 09:40:01 UTC 2023 , Edited by admin on Sat Dec 16 09:40:01 UTC 2023

PRIMARY

FDA UNII

SFN0QB7EYE

Created by admin on Sat Dec 16 09:40:01 UTC 2023 , Edited by admin on Sat Dec 16 09:40:01 UTC 2023

PRIMARY

Related Record Type Details


					K9V0CDQ56E

PARENT -> METABOLITE

Comments:

mainly catalyzed (In vitro) to sulfoxides and N-oxide by CYP2D6/3A4 in liver and FMO1 in kidney

Amount: